Royal Bank of Canada’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.51M | Buy |
824,180
+805,082
| +4,216% | +$4.4M | ﹤0.01% | 2415 |
|
|
2025
Q1 | $121K | Buy |
19,098
+15,387
| +415% | +$97.5K | ﹤0.01% | 4747 |
|
|
2024
Q4 | $15K | Sell |
3,711
-4,560
| -55% | -$18.4K | ﹤0.01% | 5744 |
|
|
2024
Q3 | $28K | Buy |
8,271
+2,729
| +49% | +$9.24K | ﹤0.01% | 5519 |
|
|
2024
Q2 | $16K | Buy |
5,542
+4,079
| +279% | +$11.8K | ﹤0.01% | 5775 |
|
|
2024
Q1 | $5K | Sell |
1,463
-12,733
| -90% | -$43.5K | ﹤0.01% | 6016 |
|
|
2023
Q4 | $19K | Buy |
14,196
+7,208
| +103% | +$9.65K | ﹤0.01% | 5800 |
|
|
2023
Q3 | $15K | Buy |
6,988
+2,645
| +61% | +$5.68K | ﹤0.01% | 5792 |
|
|
2023
Q2 | $10K | Buy |
+4,343
| New | +$10K | ﹤0.01% | 6031 |
|
|
2022
Q4 | – | Sell |
-149
| Closed | – | – | 7159 |
|
|
2022
Q3 | $0 | Buy |
+149
| New | – | ﹤0.01% | 7289 |
|